Forty-three million Americans are at risk of suffering a life-threatening allergic reaction, and the vast majority of people who suffer one turn to Mylan N.V.'s (NASDAQ: MYL) EpiPen to halt it in its ...
Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjectors may have little effect on surviving anaphylaxis events. Research is needed in ...
Forty-three million Americans are at risk of suffering a life-threatening allergic reaction, and the vast majority of people who suffer one turn to Mylan N.V. 's(NASDAQ: MYL) EpiPen to halt it in its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback